Drug Discovery World

NOVEMBER 24, 2023

The University of Queensland’s re-engineered clamp platform has produced a vaccine that is equally safe and virus-neutralising as an approved Covid vaccine considered among the best in its class. The pivotal proof-of-concept testing clears the way to progress the Clamp2 technology in a range of research programmes. Project leader, Associate Professor Keith Chappell, said the preliminary clinical trial results were an ‘exciting reward’ for the team’s continued dedication and the community’s wi

Clinical Trials 278

Clinical Trials Engineering Vaccine Trials 278

Drug Target Review

NOVEMBER 24, 2023

Researchers have explored systems that can deliver drugs directly to tumours in hope to reduce chemotherapy side effects. The use of nanoparticles, which are around the size of a virus particle, is a very promising delivery method for overcoming chemotherapy issues. Therapeutic and diagnostic nanoparticles typically fall into two categories: inorganic nanoparticles (eg, gold, silica, iron oxide, etc) and organic nanoparticles (eg, polymeric, liposomes, micelles, etc). 1 Dr Ninh (Irene) La-Beck,

Immune Response 111

Immune Response Pharmacy Treatment Virus 111

Drug Discovery World

NOVEMBER 24, 2023

Patrick Speedie , Co-Founder & Co-CEO of  IN-PART , explores why a global approach is needed for the best science to prosper and the lessons industry can take from the Covid-19 pandemic.   The Covid-19 pandemic unequivocally demonstrated the power of industry-academia collaboration, with the fastest ever development, testing and approval of a life-saving vaccine.

Research 148

Research Vaccine Science International 148

Drugs.com

NOVEMBER 24, 2023

FRIDAY, Nov. 24, 2023 -- Robert Fleetwood, 73, needed joint replacements in both knees, both to relieve his arthritis pain and to continue competing in athletic activities.And thanks to medical advances, Fleetwood was able to go home the same he.

105

105

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Drug Discovery World

NOVEMBER 24, 2023

AstraZeneca has announced that the National Institute for Health and Care Excellence (NICE) has recommended Imfinzi (durvalumab) in combination with gemcitabine and cisplatin (chemotherapy) for NHS use in England and Wales for the first-line treatment of adults with locally advanced, unresectable, or metastatic biliary tract cancer (BTC). 1 There remains a significant unmet need for new treatment options in BTC, a group of rare and aggressive cancers that occur in the bile ducts and gallbladder,

Therapies 130

Therapies Licensing Licensing Treatment 130

Drugs.com

NOVEMBER 24, 2023

FRIDAY, Nov. 24, 2023 -- Some folks feasting this holiday have to contend with gastroesophageal reflux disease, also known as GERD.In fact, about one-third of the population is affected by this chronic condition, according to the Academy of.

Disease 105

Disease 105

biobide

NOVEMBER 24, 2023

In the realm of molecular biology and toxicology, the terms "genotoxicity" and "mutagenicity" are often used interchangeably, but they refer to distinct concepts with unique implications. Understanding these differences is crucial for assessing the potential risks associated with various substances and environmental factors. Due to this, it is vital to delve into the intricacies of genotoxicity and mutagenicity, shedding light on their definitions, mechanisms, and significance.

Molecular Biology 64

Molecular Biology 64

Drug Patent Watch

NOVEMBER 24, 2023

Annual Drug Patent Expirations for RINVOQ Rinvoq is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are twenty-six patents protecting… The post New patent for Abbvie drug RINVOQ appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

Cytel

NOVEMBER 24, 2023

Regulatory requirements regarding documentation for new medicines are constantly evolving. Previously, randomized controlled trials alone qualified as high-level evidence in pharmaceutical development — today, approval is often followed by requirements for additional post-approval studies or for so-called real-world evidence (RWE) studies. Here, I’ll explain these concepts and share epidemiological and statistical methods to tackle RWE challenges.

Pharmaceuticals 59

Pharmaceuticals Trials Clinical Development 59

Drug Patent Watch

NOVEMBER 24, 2023

Annual Drug Patent Expirations for XYOSTED+%28AUTOINJECTOR%29 Xyosted (autoinjector) is a drug marketed by Antares Pharma Inc and is included in one NDA. It is available from one supplier. There are… The post New patent for Antares Pharma drug XYOSTED (AUTOINJECTOR) appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Clinical Trials

Perficient: Drug Development

NOVEMBER 24, 2023

Last week, Microsoft brought together partners, customers, and thought leaders at Microsoft Ignite , its annual conference, held this year in Seattle. This year’s event featured close to 600 sessions on AI alone, which is unheard of among technology partners. Generative AI is the pinnacle of many of Microsoft’s new product announcements, including more Copilots, additional Azure features, new AI capabilities for large language models (LLMs) in Azure, and more.

Production 52

Production Government 52

Drug Patent Watch

NOVEMBER 24, 2023

This chart shows the drugs with the most patents in Croatia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Croatia? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceuticals 59

Pharmaceuticals Drugs 59